Research for the clinical innovation.
BlueHyS Med brings a proprietary technology, developed through research, clinical studies and medical innovation, into everyday clinical practice. A platform designed to support the work of healthcare professionals with a non-invasive, safe approach grounded in ongoing scientific validation.
Clinical Validation
Innovation in medicine takes much more than a good idea: it takes research, evidence and an ongoing validation process. BlueHyS Med was born from this approach, with the aim of turning proprietary technology into a practical tool supporting clinical practice.
Scientific research
The BlueHyS Method builds on the study of molecular hydrogen and its role in modulating oxidative stress and inflammatory processes.
Patented technology
The BlueHyS platform is protected by an intellectual property structure that includes an international patent application (PCT) and an Italian application.
The experience
A session of just 20 minutes to reset oxidative stress and stimulate mitochondrial vitality.
Innovation that supports clinical practice
BlueHyS Med is based on a patented proprietary technology that combines molecular hydrogen and a blend of essential micronutrients through a non-invasive transdermal protocol. The method was developed to promote systemic bioavailability of hydrogen and to fit into clinical practice as a support to therapeutic and care pathways.
Ongoing research
At the heart of the BlueHyS Method is a platform developed to deliver molecular hydrogen through the skin, without invasive procedures, enhancing the role of the proprietary blend of micronutrients.
Non-invasive protocol
The treatment involves immersing hands and feet in warm water enriched with micronutrients. A simple, standardised and customisable protocol, designed to fit easily into clinical practice.
Non-invasive transdermal delivery
The treatment in detail
Assessment and personalisation
Every treatment begins with an assessment of the person’s needs, to define a protocol tailored to the clinical context and the goals of the programme.
The treatment
For about 20-30 minutes, hands and feet are immersed in warm water (37-42 °C) enriched with a blend of essential micronutrients, while the device generates molecular hydrogen using BlueHyS proprietary technology. The treatment is non-invasive, simple and comfortable.
Integration into clinical practice
Thanks to its standardised and customisable protocol, the BlueHyS Method is designed to fit easily into care pathways, supporting the work of healthcare professionals.
Where BlueHyS Med can make a difference
Oncology
The BlueHyS Method is the subject of studies on supporting the wellbeing and quality of life of oncology patients, alongside their treatment pathways.
Regenerative medicine
BlueHyS research explores the potential of molecular hydrogen to support biological processes involved in maintaining cellular and tissue balance.
Orthopaedics
An application focused on recovery and on supporting the physiological processes involved in rehabilitation and post-operative pathways.
Clinical research
A programme of studies and partnerships with universities and research centres aimed at expanding the scientific evidence and future applications of the BlueHyS Method.
Clinical impact and safety
The BlueHyS Method is the result of a research and validation process aimed at ensuring a safe, non-invasive approach that integrates easily into clinical practice. The technology is supported by studies, partnerships with universities and research centres, and a development strategy focused on expanding the scientific evidence and potential clinical applications.
Clinical Research
BlueHyS runs a scientific research programme aimed at generating clinical evidence on the use of molecular hydrogen delivered through the BlueHyS Method. Research activities are carried out in partnership with universities, IRCCS research hospitals and leading clinical centres in Italy and abroad, with the aim of validating the device across different fields of application through clinical and preclinical studies.
Evaluation of the feasibility, safety and efficacy of the BlueHyS Method as a support to cancer treatments.
Evaluation of the efficacy of the BlueHyS Method in knee osteoarthritis.
Research that continues to evolve
The BlueHyS Method continues to develop through ongoing intellectual property protection, scientific research and clinical validation, with the aim of strengthening the evidence behind it and broadening its applications.
INTELLECTUAL PROPERTY
A protected technology
BlueHyS holds an international patent application (PCT/EP2023/058095) and an Italian patent application (IT102023000020361), protecting its proprietary technology and its future development.
CLINICAL STUDIES
Research reaches clinical practice
The BlueHyS Method has been the subject of pilot studies in oncology at the Policlinico Sant’Orsola-Malpighi in Bologna and assessments focused on sports recovery, with the aim of further investigating its safety, tolerability and potential applications.
SCIENTIFIC VALIDATION
Research that continues
The BlueHyS platform continues to develop through partnerships with universities and research centres, and an ongoing programme of scientific studies and publications on molecular hydrogen and its applications.
Contacts
Every collaboration begins with a conversation. If you’d like to learn more about the BlueHyS Method, explore its applications, or receive more information, fill out the form: our team will be happy to assist you.